Press Release

Kirkland Represents Resonetics in Equity Investment in Medibrane

Kirkland & Ellis represented Resonetics, a provider of contract manufacturing services to the life sciences industry, in an equity investment in Medibrane, an Israel-based maker of of customized polymeric coverings and coatings. Resonetics also provided debt financing to Medibrane. Resonetics first acquired a minority ownership in Medibrane as part of its November 2018 acquisition of STI Laser. Terms of the transaction were not disclosed.

Read the company press release

The Kirkland team was led by transactional partners Sanford Perl and Michael Weed.